Table 1 Participant characteristics (n = 110)
From: Factors influencing cancer genetic somatic mutation test ordering by cancer physician
Characteristic | Participants |
|---|---|
Years since medical school, No. (%) | |
0–10 | 4 (3.6) |
11–20 | 43 (39.1) |
21–30 | 43 (39.1) |
> 30 | 15 (13.6) |
Not completed | 5 (4.6) |
Physicians caring for cancer patients, % | |
Oncologist | 58 (52.7) |
Non-oncologist (haematologist, pulmonologists, surgeons etc.) | 51 (46.7) |
No. of unique patients per annum (based on monthly estimates) | |
All physicians (Mean) | 1196.4 |
Oncologists (Mean) | 1041.0 |
Availability/Accessibility of molecularly indicated agents,%a | |
Mean | 39.13 |
Extent to which tumour pathology informs treatment choices as compared to tumour molecular profile, cmb | |
Mean | 4.06 |
Median | 3.60 |
Low levels of confidence relating to somatic genomic results, No. (%) | |
Interpreting | 56 (50.9) |
Explaining | 44 (40.0) |
Making treatment recommendations | 52 (47.3) |
Mean | 50.7 (46.1) |
Low levels of confidence in identifying consultants | |
No. (%) | 31 (28.2) |